The weekly departmental seminars are given by invited guest speakers during the academic year, to the Lautenberg faculty members and students together with other members of  the IMRIC institute and the faculty of medicine .

Next seminar:

Seminars will be renewed with the 2020 academic year

Previuos seminars:

Prof. Yariv Wine

Department of molecular genetics, Tel Aviv University

June 4th, 2019. 

Subject: Next Generation Sequencing and Proteomics for Antibody Repertoire analysis and Antibody Discovery

Prof. Noam GInossar

Department of molecular genetics, The Weizmann Institute

May 21th, 2019.

Subject: HCMV Latent Infection- Lessons from Single Cell Analyses

Prof. Mordechay (Motti) Gerlic

Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University


April 30th, 2019. 

Subject: Communication between necroptotic cells and their surrounding

Dr. Ziv Shulman

Weizmann Institute of Science

April 16th, 2019.

Subject: Dynamics of B cell immune responses in intestinal tissues

Dr. Ronen Hazan

The institute of Dental Science, HUJI

March 19th, 2019. at 12:10 (Refreshments at 12:00), Hall “Z” (אולם ז), third floor. 

Subject: the promise of phage therapy

Dr. Jakub Abramson

Department of Immunology, Weizmann Institute of Science

March 12th, 2019.

Subject: Thymic tuft cells

Prof. Vered Padler-Karavani

Department of Cell Research and Immunology, TAU

February 26th, 2019.

Subject: Immunological responses against glycosylated biotherapeutics and biodevices in humans

Prof. Eyal Gottlieb

Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology

February 19th, 2019.

Subject: Metabolic liabilities of TCA cycle truncated tumors

Dr. Dina Schneidman

Department of Biological Chemistry, Institute of Life Sciences, School of Computer Science and Engineering, HUJI

February 12th, 2019.

Subject: Predicting epitopes using integrative structure modeling

Dr. Yanay Ofran

Head – Systems Biology & Functional Genomics, Mina and Everard Goodman Faculty of Life Sciences

February 5th, 2019.

Subject: Computational Design of antibodies

Dr. Ariel Munitz

Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University

December 25th, 2018.

Subject: Emerging Roles For Eosinophils in the Tumor microenvironment

Dr. Leeat Keren

Stanford University School of Medicine

October 23rd 2018


Subject:  Unraveling the tumor immune microenvironment using multiplexed imaging.

Dr. Arthur A. Vandenbark

Portland VA Medical Center, Oregon Health & Science University

October 9th, 2018.


Subject: MIF-CD74 interactions

Prof. Yardena Samuels

Dept. of Molecular Cell Biology, Weizmann Institute of Science

June 26, 2018


Towards deciphering the neo-antigenic and T cell receptor landscapes in melanoma.

Dr. Tal Shai

Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 

June 5, 2018


Identifying differential splicing in the immune system from RNA sequencing data

Dr. Irit Gat-Viks

School of Molecular Cell Biology and Biotechnology, Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University

May 29, 2018

Revealing the immune basis of disease: a computational approach

Dr. Tal Burstyn-Cohen

Institute for Dental Sciences Hebrew University-Hadassah Jerusalem, Israel

May 22, 2018

PROS1 inhibits tumor metastasis by curbing inflammation

Prof. Steffen Jung

Department of Immunology Weizmann Institute of Science

May 1, 2018

Not just glue – Studying Microglia

Prof. Neta Erez

Sackler School of Medicine Tel Aviv University

April 10, 2018

Cancer-Associated Fibroblasts Link Tissue Damage with Tumor Promoting Inflammation in Breast Cancer

Prof. Francesco Colucci

Department of Obstetrics and Gynaecologyand Centre for Trophoblast Research University of Cambridge, England

March 13, 2018

Maternal innate lymphocytes regulatefetal development

Prof. Johan K. Sandberg

Center for Infection Medicine Department of Medicine Karolinska Institute Karolinska University Hospital Huddinge, Sweden.

Feb 15, 2018

Human MAIT cells in health and disease

Dr. Gal Cafri:

Surgery Branch

National Cancer Institute, Bethesda USA

July 4, 2017

Immunotherapeutic targeting of somatic mutations in human cancers

Prof. Ygal Haupt:

Tumour Suppression Laboratory

The Peter MacCallum Cancer Center, Melbourne, Australia

June 28, 2017

Restoration of tumour suppression in hormone related cancers

Prof. Shai Izraeli: 

Department of Molecular Genetics & Biochemistry

Sackler Faculty of Medicine, Tel Aviv University

May 23, 2017

Prof. Gidi Rechavi:

The Sheba Cancer Center 

Sheba Medical Center Hospital- Tel Hashomer, Ramat Gan

May 16, 2017

Prof. Yossi Shiloh:

Department of Human Molecular Genetics & Biochemistry

Sackler School of Medicine,Tel Aviv University, Israel

May 9, 2017

The DNA damage response: a matter of checks and balances

Dr. Arthur Machlenkin:

Head of Immunology Group at Compugen

Holon, Israel

April 25, 2017


Dr. Eyal Raz:

Division of Rheumatology, Allergy & Immunology

University of California San Diego, USA

April 18, 2017

Dr. Yaqub Hanna:

Department of Molecular Genetics

Weizmann Institute of Science, Rehovot, Israel

March 21, 2017

Molecular Mechanisms Regulating Deterministic Induction of Naïve Pluripotency 

Prof. Adit Ben-Baruch:

Department of cell Research and Immunology

Tel Aviv University, Israel

March 7, 2017 

The cholinergic tradeoff of stress micromanagement

Prof. Yuval Shaked:

Nano Biotechnology and Nanomedicine

Technion Institute of Technology, Haifa, Israel

Febuary 28, 2017

Breakthrough in Targeting the Cancer Immunome

Dr. Igor Ulitsky:

Department of Biological Regulation

Weizmann Institute of Science, Rehovot, Israel

January 31, 2017

Functions and Modes of Action of Long Noncoding RNAs in Mammalian Cells.

Prof. Michal Schwartz:


Weizmann Institute of Science, Rehovot, Israel

January 24, 2017

Harnessing adaptive immunity by immune checkpoint blockade for fighting Alzheimer’s disease.


Dr. Noga Ron Harel:

Department of Cell Biology

Harvard Medical School, Boston, MA, USA

January 17. 2017

Fueling immunity: mitochondrial rewiring drives anabolic metabolism for T cell activation.

Dr. Amir Orian:

Polak Cancer Center, Rappaport Faculty of Medicine

Technion Institute of technology, Haifa, Israel

January 10, 2017

Specifiction and maintenance of enterocytes identity

Dr. Michal Goldberg:

The Department of Genetics, The Alexander Silberman Institute of Life Sciences

The Hebrew University, Jerusalem, Israel

January 3, 2017

Spironolactone – a novel role for FNA approved drug in cancer theraphy

Dr. Michal Lotem:

Melanoma and Cancer Immunotherapy

The Hebrew University, Jerusalem, Israel

December 27, 2016

SLAMF6- a novel modulatory receptor for anti-tumor immunotherapy 

Dr. Asaf Spiegel:

Whitehead Institute for Biomedical Research

Cambridge, MA, USA

December  20, 2016

Immune Cell Regulation of the Metastatic Niche- Survival, Extravasation and Beyond.

Dr. Gary J. Nabel:

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Maryland, USA

December 8, 2016 

Harnessing Novel Immune Technologies Against Influenza, HIV and Cancer

Dr. Hermona Soreq:

The Center for Brain Sciences

The Hebrew University, Jerusalem, Israel

November 29, 2016

The cholinergic tradeoff of stress micromanagement


Dr. Cyril Cohen:

Laboratory of Tumor Immunology and Immunotherapy

Bar Ilan University, Ramat Gan, Israel

November 22, 2016

T-cell anti-tumor immunity-bridging between personalized medicine and immunotherapy